Insights

Strong Funding Backing With recent financing rounds totaling over 85 million USD, SmartCella demonstrates significant financial robustness, indicating potential for upcoming partnerships and collaborative projects in innovative targeted therapies.

Strategic Leadership The appointment of industry experienced leaders including a former head of R&D from major pharma companies and a new CEO suggests that SmartCella is positioning itself for accelerated growth and market expansion, presenting opportunities for strategic alliances.

Innovative Delivery Platforms SmartCella’s proprietary technologies such as Extroducer and its focus on stem cell therapies suggest a strong pipeline of novel treatment solutions, ideal for companies looking to integrate advanced delivery systems into their offerings.

US Market Expansion With recent hires focused on accelerating US market entry, there are emerging opportunities for collaboration with organizations seeking access to cutting-edge regenerative medicines and targeted therapy solutions.

Focus on Growth and Research SmartCella’s ongoing investments in expanding its scientific advisory board and team indicate a commitment to innovation and research, providing potential avenues for partnership in joint development projects or licensing of novel technologies.

Procella Therapeutics AB Tech Stack

Procella Therapeutics AB uses 8 technology products and services including Cloudflare, oEmbed, Highstock, and more. Explore Procella Therapeutics AB's tech stack below.

Cloudflare

Content Management System

oEmbed

Dev Tools

Highstock

Javascript Graphics

JsRender

Javascript Libraries

JsViews

Javascript Libraries

Microsoft

Miscellaneous

Bootstrap

UI Frameworks

Facebook

Widgets

Procella Therapeutics AB Email Formats	Example	Percentage
First.Last@procella.se	John.Doe@procella.se	98%
First.Middle.Last@procella.se	John.Michael.Doe@procella.se	2%
First.Last@smartcella.com	John.Doe@smartcella.com	100%

Procella Therapeutics AB Email Formats

Example

Percentage

First.Last@procella.se

John.Doe@procella.se

98%

First.Middle.Last@procella.se

John.Michael.Doe@procella.se

First.Last@smartcella.com

John.Doe@smartcella.com

100%

Frequently Asked Questions

What is Procella Therapeutics AB's official website and social media links?

Procella Therapeutics AB's official website is smartcella.com and has social profiles on LinkedIn Crunchbase.

What is Procella Therapeutics AB's SIC code NAICS code?

Procella Therapeutics AB's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Procella Therapeutics AB have currently?

As of February 2026, Procella Therapeutics AB has approximately 70 employees across 2 continents, including EuropeNorth America. Key team members include Coo: J. R.Chief Commercial Officer (cco): S. O.Chief Financial Officer: O. S.. Explore Procella Therapeutics AB's employee directory with LeadIQ.

What industry does Procella Therapeutics AB belong to?

Procella Therapeutics AB operates in the Biotechnology Research industry.

What technology does Procella Therapeutics AB use?

Procella Therapeutics AB's tech stack includes CloudflareoEmbedHighstockJsRenderJsViewsMicrosoftBootstrapFacebook.

What is Procella Therapeutics AB's email format?

Procella Therapeutics AB's email format typically follows the pattern of First.Last@procella.se. Find more Procella Therapeutics AB email formats with LeadIQ.

How much funding has Procella Therapeutics AB raised to date?

As of February 2026, Procella Therapeutics AB has raised $54M in funding. The last funding round occurred on Jul 08, 2024 for $54M.

When was Procella Therapeutics AB founded?

Procella Therapeutics AB was founded in 2014.

Procella Therapeutics AB

Q: How many employees does Procella Therapeutics AB have currently?

Procella Therapeutics AB has approximately 70 employees.

Q: What technology does Procella Therapeutics AB use?

Procella Therapeutics AB's tech stack includes PHP, Cloudflare Bot Management, Google Analytics, oEmbed, Cloudflare.

Biotechnology ResearchStockholm, Sweden51-200 Employees

SmartCella is a global biopharma company that combines biotech methods and medical science to develop therapies from living systems and pioneers targeted therapies for difficult-to-treat diseases through delivery solutions and advanced therapy development.  Founded in 2014, the company is built on globally renowned science and research from Karolinska Institutet in Sweden. 

SmartCella combines novel delivery platforms, such as the Extroducer® (an endovascular delivery device that enables direct injection to hard-to-reach organs and tumors), with cutting-edge development and manufacturing of cell therapies. The company has two operating segments: Targeted Delivery and Regenerative Medicines.

The international team consists of scientists, visionary innovators, and experienced business leaders, all dedicated to shaping the future of targeted therapies and delivering life-changing treatments to patients.

Insights

Similar companies to Procella Therapeutics AB

Hoist Group

Free2move AB